Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.
Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.
Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.
Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.
Humana (NYSE: HUM) has announced its Board of Directors' declaration of a quarterly cash dividend of $0.885 per share. The dividend will be payable on July 25, 2025, to stockholders of record as of the close of business on June 27, 2025.
The company, which operates through Humana insurance services and CenterWell health care services, focuses on providing healthcare services to people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.
The Humana Foundation, Humana Inc.'s philanthropic arm, has released a new report titled 'Strengthening Science and Community Impact Through Equitable Research Practices'. The report analyzes innovative research methods adopted by Foundation partners to promote health equity through community-engaged research.
The report highlights three key themes:
- Expanding Access and Opportunity: Research teams collaborate with local institutions to remove participation barriers
- Promoting Community Leadership: Community members are involved in multiple research stages through advisory boards and partnerships
- Respecting Human Dignity: Projects ensure fair treatment and transparency for all participants
According to Foundation leaders, community-engaged research strategies can enhance the implementation of health equity interventions and improve long-term effectiveness.
Humana Inc. (NYSE: HUM) has released its 2024 Impact Report, highlighting significant improvements in healthcare outcomes and community support. The report showcases achievements across four key areas: people, community, healthcare system, and environment.
Key highlights include:
- Medicare Advantage members experienced 11.6% fewer ER visits and 7.2% fewer hospital admissions under value-based care
- 423,690 Social Determinants of Health screenings conducted for Medicaid members, up 21% from 2023
- The Humana Foundation granted $14.2 million to over 30 organizations
- Interoperability infrastructure connects 750,000+ providers with 200 million shared clinical records across 5.6 million members
- Environmental initiatives resulted in 14.5% reduction in Scope 1 and 2 emissions
Humana Inc. (NYSE: HUM) has announced key dates for its upcoming financial events. The company will release its first quarter 2025 (1Q25) financial results on Wednesday, April 30, 2025, at 6:00 a.m. Eastern time, followed by a live Q&A session at 8:00 a.m. Eastern time.
Additionally, Humana will host an Investor Conference on Monday, June 16, 2025, starting at 2:00 p.m. EST. During this conference, company leaders will present on strategic direction, operational and financial progress, and future performance expectations.
Both events will be accessible via Humana's Investor Relations page, with webcasts available for replay. The 1Q25 earnings release will include both GAAP and non-GAAP financial measures, with reconciliations provided.
CenterWell Senior Primary Care is celebrating the grand opening of its new center in Gladstone, Missouri, marking the first of 23 centers planned to open near Walmart locations across four states by mid-2024. The Gladstone facility, operational since December 2024, is part of Humana's Primary Care Organization (PCO), which operates over 340 centers serving approximately 390,000 seniors.
The centers feature specialized senior care facilities with dedicated entrances, easy parking, and activity centers open to the community. The facilities are staffed by board-certified physicians, nurse practitioners, and various healthcare specialists trained in senior care. Recent data shows their value-based care model resulted in 10% more primary care visits and 278,000 fewer inpatient admissions for Medicare Advantage patients in 2023 compared to Original Medicare.
Additional centers will open near Walmart stores in Tampa/St Petersburg, Orlando, Jacksonville, Atlanta, and Dallas/Fort Worth metropolitan areas. The centers accept Original Medicare and various Medicare Advantage health plans.
CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Icon Health to provide integrated musculoskeletal care for seniors in Palm Beach County. The collaboration embeds specialized advanced practice providers in primary care centers, offering both in-person and virtual care delivery options.
The partnership focuses on treating musculoskeletal conditions like back pain, arthritis, and joint injuries, which are major causes of disability among seniors. Icon's value-based care model emphasizes early intervention, precise diagnosis, and personalized treatment plans. The program features virtual-first access to specialists, proactive coordinated care, and decision support tools for symptom identification.
The service accepts patients with Original Medicare and various Medicare Advantage plans, ensuring accessibility for eligible seniors.
Humana (NYSE: HUM) has successfully completed a $1.25 billion debt offering through senior notes. The offering consists of:
- $750 million in 5.550% senior notes due 2035 at 99.885% of principal
- $500 million in 6.000% senior notes due 2055 at 98.951% of principal
The net proceeds of approximately $1.231 billion will be used to repay the company's 4.500% Senior Notes due in April 2025, with the remainder allocated for general corporate purposes, including potential repayment of existing debt and commercial paper program borrowings. The offering was managed by Barclays Capital, BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and U.S. Bancorp Investments.
AM Best has assigned a 'bbb' (Good) rating to Humana Inc.'s new senior unsecured notes: $750 million at 5.5% due 2035 and $500 million at 6.0% due 2055. The proceeds will be used for general corporate purposes, including repayment of $600 million in existing debt due April 2025 and approximately $885 million in commercial paper.
The issuance will temporarily increase financial leverage from 42% to approximately 45%, above Humana's long-term target of 40%. While EBIT interest coverage remains solid at 5-8 times, it has declined from previous double-digit levels due to increased Medicare Advantage utilization and reimbursement changes in 2023-2024.
Humana maintains strong liquidity with $3 billion in operating cash flows and $1.5 billion in subsidiary dividends for 2024. The company's financial position is supported by $4.75 billion in credit lines and a $4 billion commercial paper program.
Humana (NYSE: HUM) has announced pricing for a $1.25 billion senior notes offering, comprising $750 million of 5.550% notes due 2035 and $500 million of 6.000% notes due 2055. The offering is expected to close on March 5, 2025.
The company anticipates net proceeds of approximately $1.231 billion after deducting underwriters' discounts and offering expenses. These funds will be primarily used to repay Humana's 4.500% Senior Notes due in April 2025, with the remainder allocated for general corporate purposes, including potential repayment of existing debt and commercial paper borrowings.
The offering is being managed by joint book-running managers including Barclays Capital, BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and U.S. Bancorp Investments.
Humana (NYSE: HUM) has announced a new value-based care partnership with Thyme Care to enhance cancer care support for eligible Medicare Advantage members. The collaboration aims to provide comprehensive oncology services through 24/7 virtual care navigation and data-driven insights.
The program is now available to eligible Humana Medicare Advantage members in seven states: Michigan, New York, Illinois, Indiana, Tennessee, Pennsylvania, and New Jersey. Key services include:
- 24/7 virtual care navigation with dedicated oncology care teams
- Community support for resources like financial assistance and transportation
- Coordinated care between oncologists, primary care physicians, and specialists
The initiative focuses on reducing care gaps, minimizing unnecessary expenses, and providing comprehensive support for cancer patients while managing treatment complexities and costs.
